Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study

Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S. The weight of obesity in breast cancer progression and metastasis: clinical and molecular perspectives. Semin Cancer Biol. 2020;60:274–84.

CAS  PubMed  Article  Google Scholar 

Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34(35):4277–83.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults New England J Med. 2003;348(17):1625–38.

Article  Google Scholar 

Dai H, Alsalhe TA, Chalghaf N, Riccò M, Bragazzi NL, Wu J. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: an analysis of the global burden of disease study. PLoS Med. 2020;17(7):e1003198.

PubMed  PubMed Central  Article  Google Scholar 

Specchia ML, Veneziano MA, Cadeddu C, Ferriero AM, Mancuso A, Ianuale C, et al. Economic impact of adult obesity on health systems: a systematic review. Eur J Public Health. 2014;25(2):255–62.

PubMed  Article  Google Scholar 

Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res. 2012;5(4):515–21.

Article  Google Scholar 

Yoo K-Y, Tajima K, Park S-K, Kang D, Kim S-U, Hirose K, et al. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett. 2001;167(1):57–63.

CAS  PubMed  Article  Google Scholar 

Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the women’s health initiative (United States). Cancer Causes Control. 2002;13(8):741–51.

PubMed  Article  Google Scholar 

Macciò A, Madeddu C. Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Sci World J. 2011;11:806787.

Article  Google Scholar 

John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the san francisco bay area breast cancer study. Am J Epidemiol. 2010;173(2):201–16.

PubMed  PubMed Central  Article  Google Scholar 

Feingold KR. 2020. Obesity and Dyslipidemia. In: Kenneth R Feingold BA, Alison Boyce et al, editor. Adrenal Disease and Function: Endotext.

Yan J, Horng T. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 2020;30(12):979–89.

CAS  PubMed  Article  Google Scholar 

Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt S-M. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev Cell. 2021;56(10):1363–93.

CAS  PubMed  Article  Google Scholar 

Cruz P, Mo H, McConathy W, Sabnis N, Lacko A. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013;4:119.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Gorin A, Gabitova L, Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling. Curr Opin Pharmacol. 2012;12(6):710–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Onwuka JU, Okekunle AP, Olutola OM, Akpa OM, Feng R. Lipid profile and risk of ovarian tumours: a meta-analysis. BMC Cancer. 2020;20(1):200.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Touvier M, Fassier P, His M, Norat T, Chan DS, Blacher J, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr. 2015;114(3):347–57.

CAS  PubMed  Article  Google Scholar 

Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. (Eds.) AJCC (American Joint Committee on Cancer) Cancer Staging Manual (8th ed.). Springer; 2017.

Kim N-H, Song S, Jung S-Y, Lee E, Kim Z, Moon H-G, et al. Dietary pattern and health-related quality of life among breast cancer survivors. BMC Womens Health. 2018;18(1):65.

PubMed  PubMed Central  Article  Google Scholar 

Shin W-k, Song S, Jung S-Y, Lee E, Kim Z, Moon H-G, et al. The association between physical activity and health-related quality of life among breast cancer survivors. Health Qual Life Outcomes. 2017;15(1):132.

PubMed  PubMed Central  Article  Google Scholar 

Shin W-k, Song S, Hwang E, Moon H-G, Noh D-Y, Lee JE. Development of a FFQ for breast cancer survivors in Korea. British J Nutr. 2016;116(10):1781–6.

CAS  Article  Google Scholar 

Shin W-K, Kim Z, Youn HJ, Cho J, Lee JE. Determinants of plasma 25-Hydroxyvitamin D concentrations among breast cancer survivors in Korea. Nutrients. 2018;10(3):380.

PubMed Central  Article  CAS  Google Scholar 

Youn J, Park S, Song S, Moon H-G, Noh D-Y, Jung S-Y, et al. Nutrient intakes from supplement and factors associated with supplement use among breast cancer survivors: A cross-sectional study. Eur J Cancer Care. 2021;30:e13447. https://doi.org/10.1111/ecc.13447.

Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DRJ, Tudor-Locke C, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.

PubMed  Article  Google Scholar 

Organization WH. The Asia-Pacific perspective: Redefining obesity and its treatment: Regional Office of the Western Pacific (WPRO) World Health Organization. 2000.

Google Scholar 

Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781–5.

CAS  PubMed  Article  Google Scholar 

Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol. 2010;6(1):441.

PubMed  PubMed Central  Article  Google Scholar 

Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192–206.

CAS  PubMed  Article  Google Scholar 

Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71(6):620–32.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.

CAS  PubMed  Article  Google Scholar 

Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol. 2015;6:218.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Watanabe H, Söderlund S, Soro-Paavonen A, Hiukka A, Leinonen E, Alagona C, et al. Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families. Arterioscler Thromb Vasc Biol. 2006;26(4):897–902.

CAS  PubMed  Article  Google Scholar 

Pascot A, Lemieux I, Prud’homme D, Tremblay A, Nadeau A, Couillard C, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res. 2001;42(12):2007–14.

CAS  PubMed  Article  Google Scholar 

Tang H, Xiang Z, Li L, Shao X, Zhou Q, You X, et al. Potential role of anti-inflammatory HDL subclasses in metabolic unhealth/obesity. Artif Cells Nanomed Biotechnol. 2021;49(1):565–75.

PubMed  Article  CAS  Google Scholar 

Duparc T, Ruidavets J-B, Genoux A, Ingueneau C, Najib S, Ferrières J, et al. Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: the GENES study. Sci Rep. 2020;10(1):8138.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003;52(2):453–62.

CAS  PubMed  Article  Google Scholar 

Superko HR, Pendyala L, Williams PT, Momary KM, King SB, Garrett BC. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol. 2012;6(6):496–523.

PubMed  Article  Google Scholar 

Dobiasova M, Stribrna J, Pritchard PH, Frohlich JJ. Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J Lipid Res. 1992;33(10):1411–8.

CAS  PubMed  Article  Google Scholar 

Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients. 2013;5(2):498–508.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Assmann G, Nofer J-R. Atheroprotective effects of high-density lipoproteins. Annu Rev Med. 2003;54(1):321–41.

CAS  PubMed  Article  Google Scholar 

Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA. 2004;101(26):9774–9.

CAS  PubMed 

留言 (0)

沒有登入
gif